太阳集团见好就收9728(中国)有限公司

  • Home
  • Respect Talents
    1. Office Env
    2. Promotion Space
    3. Personnel Policy
    4. Entry Notice
    5. Benefits
    6. Job Demand

    Respect Talents

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • About Us
    1. Company Profile
    2. Company History
    3. Affiliation Structure

    About Us

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • Registration Declaration
    1. Import Registration
    2. Approved Varieties
    3. Related Varieties
    4. Variety in report
    5. Species to be reported
    6. Declared varieties

    Registration Declaration

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • R & D field
    1. R&D Catalog
    2. Psychotropic Drugs
    3. Medicinal chemistry
    4. Chemical Synthesis
    5. Chemical Analysis
    6. Pharmaceutical Preparations
    7. Pharmacological Research
    8. Drug Toxicology

    R & D field

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • R&D Equipment
    1. Equipment
    2. Laboratory

    R&D Equipment

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • News
    1. Company News
    2. Industry News
    3. Latest Announcement

    News

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • External Information

    External Information

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

  • Contact Us

    Contact Us

    VAYUAN focuses on drug synthesis, formulations, quality analysis, drug packaging compatibility research, microbiology, standard physical and chemical testing, drug registration and application, and other comprehensive drug development and drug clinical trial research.

Vayuan Medicine attaches great importance to the research and development of psychotropic drugs. It has obtained the pre-approval from the National Medical Products Administration [National Medical Products Administration-(NMPA)] to establish a psychotropic drug research laboratory.

The second-class psychotropic drug "phenobarbital tablets" successfully passed the relocation: On August 27, 2018, the Shanghai Food and Drug Administration approved the relocation production application of "phenobarbital tablets" and agreed to the production address of this product Changed from No. 1888, Zhuxin Road, Jinshan Industrial Zone, Shanghai to No. 428, Xihan Road, Fengxian District, Shanghai.

The second-class psychotropic drug "phenobarbital tablets" successfully obtained the drug GMP certificate: On February 2, 2019, Vayuan Pharmaceutical Co., Ltd. successfully obtained the "drug GMP certificate".

Approval for the approval of the first-class psychotropic drug research laboratory project: Vayuan Pharmaceutical Co., Ltd. obtained the first-class psychoactive drug experimental research approval approved by the State Drug Administration on June 11, 2019, with the approval number: TYL2019-0139.

The second-class psychotropic drug caffeine tablets project approval was approved: Vayuan Pharmaceutical Co., Ltd.'s second-class psychoactive drug "caffeine tablets" was approved for experimental research by the National Medical Products Administration on November 6, 2019, approval number: TYL2019- 0240.

The consistency evaluation of the second-class psychotropic drug "phenobarbital tablets" entered the key link: the formal BE was successfully registered in CDE, registration numbers: CTR20200901CTR20201416, and the experimental status has been officially launched.


33.jpg


Qingdao Vayuan Pharmaceutical Technology Ltd.

TEL:0532-55678600

Fax:0532-55678586

Email:ad@vayuan.com

Time:Monday to Friday 8:30~12:00; 13:00~17:30

Address:11th Floor, No.377 Nanjing Rd. Qingdao City, Shandong Province, China

Telephone

+86-0532-55678600

Copyright © 2018-2020 Qingdao Vayuan Pharmaceutical Technology Ltd. All Rights Reserved. 备案号:鲁ICP备20020049号

XML 地图 | Sitemap 地图